Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2012, Article ID 940580, 10 pages
Research Article

Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-year Retrospective Review from Zaria, Northern Nigeria

1Department of Medicine, Niger Delta University, PMB 071, Amassoma, Bayelsa State, Nigeria
2Department of Medicine, Ahmadu Bello University Teaching Hospital, PMB 06, Zaria, Kaduna State, Nigeria
3Department of Haematology, Ahmadu Bello University Teaching Hospital, PMB 06, Zaria, Kaduna State, Nigeria

Received 17 May 2012; Revised 6 August 2012; Accepted 8 August 2012

Academic Editor: Robin Wood

Copyright © 2012 Dimie Ogoina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. This study, undertaken in major tertiary hospital in northern Nigeria, examined the morbidity and mortality patterns of hospitalised adult HIV/AIDS patients in the HAART era. Methods. Between January 2006 and December 2009, admission records and causes of deaths of hospitalised medical HIV-infected patients were retrieved and analysed according to antiretroviral (ART) status. Results. Of the 207 HIV/AIDS patients reviewed, majority were newly diagnosed (73.4%), and most were hospitalised and died from various AIDS-defining illnesses, mainly disseminated tuberculosis and sepsis. Immune-inflammatory-reconstitution-syndrome, ART-toxicity and ART-failure, contributed to morbidity and mortality in patients receiving ART. Sixty six (31.9%) patients died, with higher mortality in males and in those with lower CD4-cell count, lower PCV, and shorter hospital stay. However, hospital stay ≤3 days and severe anaemia (PCV < 24%) were independent predictors of mortality. Conclusion. In the current HAART era, late presentation and tuberculosis continue to fuel the HIV/AIDS pandemic in Africa, with emerging challenges due to ART-related complications.